K Zvinoera1, I D Olaru2,3, P Khan2, J Mutsvangwa3, C M Denkinger4,5, V Kampira1, D Coutinho1, H Mutunzi6, M Pepukai3, E Chikaka7, S Zinyowera8, S Mharakurwa7, K Kranzer2,3,9. 1. Ministry of Health and Child Care, Mutare Provincial Hospital, Mutare, Zimbabwe. 2. Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK. 3. Biomedical Research and Training Institute, Harare, Zimbabwe. 4. Division of Tropical Medicine, Centre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany. 5. German Centre for Infection Research (DZIF), partner site Heidelberg University Hospital, Heidelberg, Germany. 6. AIDS and TB Department, Ministry of Health and Child Care, Harare, Zimbabwe. 7. Department of Health Sciences, College of Health and Natural Sciences, Africa University, Old Mutare, Zimbabwe. 8. National Microbiology Reference Laboratory, Ministry of Health and Child Care, Harare, Zimbabwe. 9. Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich, Munich, Germany.
Abstract
SETTING: Governmental health facilities performing TB diagnostics in Manicaland, Zimbabwe. OBJECTIVE: To investigate the effect of making Xpert® MTB/RIF the primary TB diagnostic for all patients presenting with presumptive TB on 1) the number of samples investigated for TB, 2) the proportion testing TB-positive, and 3) the proportion of unsuccessful results over time. DESIGN: This retrospective study used data from GeneX-pert downloads, laboratory registers and quality assurance reports between 1 January 2017 and 31 December 2018. RESULTS: The total number of Xpert tests performed in Manicaland increased from 3,967 in the first quarter of 2017 to 7,011 in the last quarter of 2018. Mycobacterium tuberculosis DNA was detected in 4.9-8.6% of the samples investigated using Xpert, with a higher yield in 2017 than in 2018. The overall proportion of unsuccessful Xpert assays due to "no results", errors and invalid results was 6.3%, and highly variable across sites. CONCLUSION: Roll out of more sensitive TB diagnostics does not necessarily result in an increase of microbiologically confirmed TB diagnosis. While the number of samples tested using Xpert increased, the proportion of TB-positive tests decreased. GeneXpert soft- and hardware infrastructure needs to be strengthened to reduce the rate of unsuccessful assays and therefore, costs and staff time.
SETTING: Governmental health facilities performing TB diagnostics in Manicaland, Zimbabwe. OBJECTIVE: To investigate the effect of making Xpert® MTB/RIF the primary TB diagnostic for all patients presenting with presumptive TB on 1) the number of samples investigated for TB, 2) the proportion testing TB-positive, and 3) the proportion of unsuccessful results over time. DESIGN: This retrospective study used data from GeneX-pert downloads, laboratory registers and quality assurance reports between 1 January 2017 and 31 December 2018. RESULTS: The total number of Xpert tests performed in Manicaland increased from 3,967 in the first quarter of 2017 to 7,011 in the last quarter of 2018. Mycobacterium tuberculosis DNA was detected in 4.9-8.6% of the samples investigated using Xpert, with a higher yield in 2017 than in 2018. The overall proportion of unsuccessful Xpert assays due to "no results", errors and invalid results was 6.3%, and highly variable across sites. CONCLUSION: Roll out of more sensitive TB diagnostics does not necessarily result in an increase of microbiologically confirmed TB diagnosis. While the number of samples tested using Xpert increased, the proportion of TB-positive tests decreased. GeneXpert soft- and hardware infrastructure needs to be strengthened to reduce the rate of unsuccessful assays and therefore, costs and staff time.
Authors: David J Horne; Mikashmi Kohli; Jerry S Zifodya; Ian Schiller; Nandini Dendukuri; Deanna Tollefson; Samuel G Schumacher; Eleanor A Ochodo; Madhukar Pai; Karen R Steingart Journal: Cochrane Database Syst Rev Date: 2019-06-07
Authors: Collins Timire; Charles Sandy; Ajay M V Kumar; Mkhokheli Ngwenya; Barbara Murwira; Kudakwashe C Takarinda; Anthony D Harries Journal: Int J Infect Dis Date: 2019-02-15 Impact factor: 3.623
Authors: Jacob Creswell; Andrew J Codlin; Emmanuel Andre; Mark A Micek; Ahmed Bedru; E Jane Carter; Rajendra-Prasad Yadav; Andrei Mosneaga; Bishwa Rai; Sayera Banu; Miranda Brouwer; Lucie Blok; Suvanand Sahu; Lucica Ditiu Journal: BMC Infect Dis Date: 2014-01-02 Impact factor: 3.090
Authors: Lucia Cilloni; Han Fu; Juan F Vesga; David Dowdy; Carel Pretorius; Sevim Ahmedov; Sreenivas A Nair; Andrei Mosneaga; Enos Masini; Suvanand Sahu; Nimalan Arinaminpathy Journal: EClinicalMedicine Date: 2020-10-24
Authors: Elisa Ardizzoni; Emmanuel Fajardo; Peter Saranchuk; Martina Casenghi; Anne-Laure Page; Francis Varaine; Cara S Kosack; Pamela Hepple Journal: PLoS One Date: 2015-12-15 Impact factor: 3.240
Authors: Alexandra B Hogan; Britta L Jewell; Ellie Sherrard-Smith; Juan F Vesga; Oliver J Watson; Charles Whittaker; Arran Hamlet; Jennifer A Smith; Peter Winskill; Robert Verity; Marc Baguelin; John A Lees; Lilith K Whittles; Kylie E C Ainslie; Samir Bhatt; Adhiratha Boonyasiri; Nicholas F Brazeau; Lorenzo Cattarino; Laura V Cooper; Helen Coupland; Gina Cuomo-Dannenburg; Amy Dighe; Bimandra A Djaafara; Christl A Donnelly; Jeff W Eaton; Sabine L van Elsland; Richard G FitzJohn; Han Fu; Katy A M Gaythorpe; William Green; David J Haw; Sarah Hayes; Wes Hinsley; Natsuko Imai; Daniel J Laydon; Tara D Mangal; Thomas A Mellan; Swapnil Mishra; Gemma Nedjati-Gilani; Kris V Parag; Hayley A Thompson; H Juliette T Unwin; Michaela A C Vollmer; Caroline E Walters; Haowei Wang; Yuanrong Wang; Xiaoyue Xi; Neil M Ferguson; Lucy C Okell; Thomas S Churcher; Nimalan Arinaminpathy; Azra C Ghani; Patrick G T Walker; Timothy B Hallett Journal: Lancet Glob Health Date: 2020-07-13 Impact factor: 26.763
Authors: Najmul Haider; Abdinasir Yusuf Osman; Audrey Gadzekpo; George O Akipede; Danny Asogun; Rashid Ansumana; Richard John Lessells; Palwasha Khan; Muzamil Mahdi Abdel Hamid; Dorothy Yeboah-Manu; Leonard Mboera; Elizabeth Henry Shayo; Blandina T Mmbaga; Mark Urassa; David Musoke; Nathan Kapata; Rashida Abbas Ferrand; Pascalina-Chanda Kapata; Florian Stigler; Thomas Czypionka; Alimuddin Zumla; Richard Kock; David McCoy Journal: BMJ Glob Health Date: 2020-10